The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Nevada Assembly Speaker Steve Yeager on Thursday introduced an emergency bill draft request that would cap the cost of ...